Treatment of adolescent rats with 1-benzylpiperazine: a preliminary study of subsequent behavioral effects

Neurotoxicology and Teratology

Volumn 28, Issue 4, 2006, Pages 453-458

  Aitchison, Lara K ^a   Hughes, Robert N ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

1 benzylpiperazine; Adolescence; Anxiety; Rats

Indexed keywords

1 BENZYLPIPERAZINE DERIVATIVE; SEROTONIN; SODIUM CHLORIDE;

ADOLESCENCE; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; BRIGHTNESS; CONTROLLED STUDY; DEFECATION; FEMALE; FOREBRAIN; LATENT PERIOD; LIGHT DARK CYCLE; MALE; MAZE TEST; MOBILIZATION; NONHUMAN; OPEN FIELD BEHAVIOR; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; REARING; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SOCIAL INTERACTION;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; FEMALE; INTERPERSONAL RELATIONS; LIGHT; MALE; MOTOR ACTIVITY; PIPERAZINES; RATS; SEX CHARACTERISTICS;

EID: 33748302062     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2006.05.005     Document Type: Article

References (53)

1. Aitken P.P. Aversive stimulation and rats' preference for areas differing in novelty-value and brightness. Anim. Behav. 22 (1974) 731-734
2. Allan B. Party poppers. Consumer (New Zealand) 447 (2005) 28-29
3. Anderson S.L. Trajectories of brain development: point of vulnerability or window of opportunity. Neurosci. Biobehav. Rev. 27 (2003) 3-18
4. Archer J. Tests for emotionality in rats and mice: a review. Anim. Behav. 21 (1973) 205-235
5. Archer J. Rodent sex differences in emotional and related behavior. Behav. Biol. 14 (1975) 451-479
6. Baranyi J., Bakos N., and Haller J. Social instability in female rats: the relationship between stress-rated and anxiety-like consequences. Physiol. Behav. 84 (2005) 511-518
7. Baumann M.H., Ayestas M.A., Sharpe L.G., Lewis D.B., Rice K.C., and Rothman R.B. Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR 12909 decanoate. J. Pharmacol. Exp. Ther. 301 (2002) 1190-1197
8. Baumann M.H., Clark R.D., Budsynski A.G., Partilla J.S., Blough B.E., and Rothman R.B. Effects of "legal X" piperazine analogs on dopamine and serotonin release in rat brain. Ann. N. Y. Acad. Sci. 1025 (2004) 189-197
9. Baumann M.H., Clark R.D., Budsynski A.G., Partilla J.S., Blough B.E., and Rothman R.B. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'ecstasy'). Neuropsychopharmacology 30 (2005) 550-560
10. Bielsky I.F., and Young L.J. Oxytocin, vasopressin, and social recognition in mammals. Peptides 25 (2004) 1565-1574
11. M. Bowden, Non-traditional designer substances: a new category of psychoactives in New Zealand, retrieved 29 March 2006 from URL: http://www.erowid.org/chemicals/bzp/bzp_info1.shtml.
12. Bye C., Munro-Faure A.D., Peck A.W., and Young P.A. A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests. Eur. J. Clin. Pharmacol. 6 (1973) 163-169
13. Campbell H., Cline W., Evans M., Lloyd J., and Peck A.W. Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. Eur. J. Clin. Pharmacol. 6 (1973) 170-176
14. Carlezon W.A., Mague S.D., and Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol. Psychiatry 54 (2003) 1330-1337
15. Chambers R.A., Taylor J.R., and Potenza M.N. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am. J. Psychiatry 160 (2003) 1041-1052
16. Clemens K.J., van Nieuwenhuyzen P.S., Li K.M., Cornish J.L., Hunt G.E., and McGregor I.S. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology 173 (2004) 318-325
17. de Almeida R.M.M., Ferrari P.F., Parmigiani S., and Miczek K.A. Escalated aggressive behavior: dopamine, serotonin and GABA. Eur. J. Pharmacol. 526 (2005) 51-64
18. de Jong T.R., Snaphaan L.J.A.E., Pattij T., Veening J.G., Waldinger M.D., Cools A.R., and Olivier B. Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats. Eur. Neuropsychopharmacol. 16 (2006) 39-48
19. Fantegrossi W.E., Winger G., Woods J.H., and Woolverton W.L. A. Coop, Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug Alcohol Depend. 77 (2005) 161-168
20. File S.E. The social interaction test of anxiety. In: Wouterlood F.H. (Ed). Neuroscience Protocols (1993), Elsevier Science Publishers B.V., Amsterdam 1-7
21. File S.E., and Seth P. A review of 25 years of the social interaction test. Eur. J. Pharmacol. 463 (2003) 35-53
22. P. Gee, S. Richardson, W. Woltersdorf, G. Moore, Toxic effects of BZP-based party pills in humans: a prospective study in Christchurch, New Zealand, NZ Med J 118 (2005) retrieved 29 March 2006 from URL: http://www.nzma.org.nz/journal/118-1227/1784/.
23. Graeff F.G. On serotonin and experimental anxiety. Psychopharmacology 163 (2002) 467-476
24. Gray J.A. Sex differences in emotional behavior in mammals including man: endocrine bases. Acta Psychol. 35 (1971) 29-46
25. Gurtman C.G., Morley K.C., Li K.M., Hunt G.E., and McGregor I.S. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur. J. Pharmacol. 446 (2002) 89-96
26. Hascoët M., Bourin M., and Dhonnchadha B.A. The mouse light-dark box paradigm: a review. Prog. Neuropsychopharmacol. Biol. Psychiatry 25 (2001) 141-166
27. Hashimoto K., Maeda H., and Goromaru T. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain. Brain Res. 590 (1992) 341-344
28. Hirsjarvi P., and Valiaho T. Effects of gentling on open-field behavior of Wistar rats in fear-evoking test situation. Lab. Anim. 29 (1995) 380-384
29. 1A agonist. Pharmacol. Biochem. Behav. 82 (2005) 549-558
30. Hughes R.N. Effects of adrenalin on novelty choices and activity in rats. Life Sci. 41 (1987) 25-29
31. Hughes R.N. Responsiveness to brightness change in hooded rats: effects of sex and procedure. Behav. Processes 55 (2001) 143-155
32. Hughes R.N. Effects of glucose on responsiveness to change in young adult and middle-aged rats. Physiol. Behav. 78 (2003) 529-534
33. Hughes R.N. Responsiveness to brightness change in male and female rats following treatment with the partial agonist of the N-methyl-d-aspartate receptor, d-cycloserine. Behav. Brain Res. 152 (2004) 199-207
34. Hughes R.N., and Beveridge I.J. Effects of prenatal exposure to chronic caffeine on locomotor and emotional behavior. Psychobiology 15 (1987) 179-185
35. Hughes R.N., and Beveridge I.J. Behavioral effects of exposure to caffeine during gestation, lactation or both. Neurotoxicol. Teratol. 13 (1991) 641-647
36. Hughes R.N., and Greig A.M. Effects of caffeine, methamphetamine and methylphenidate on reactions to novelty and activity in rats. Neuropharmacology 15 (1976) 673-676
37. Hughes R.N., and Neeson L.T. Prevention of memory loss for a brightness change in adult and middle-aged rats by postacquisition treatment with glucose. Pharmacol. Biochem. Behav. 76 (2003) 119-123
38. Johnston A.L., and File S.E. Sex differences in animal tests of anxiety. Physiol. Behav. 49 (1991) 245-250
39. Laviola G., Adriani W., Terranova M.L., and Gerra G. Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci. Biobehav. Rev. 23 (1999) 993-1010
40. Levin E.D., Briggs S.J., Christopher N.C., and Rose J.E. Prenatal nicotine exposure and cognitive performance in rats. Neurotoxicol. Teratol. 14 (1993) 251-260
41. London E.D., Simon S.L., Berman S.M., Mandelkern M.A., Lichtman A.M., Braman J., Shinn A.K., Miotto K., Learn J., Dong Y., Matochik J.A., Kurian V., Newton T., Woods R., Rawson R., and Ling W. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch. Gen. Psychiatry 61 (2004) 73-84
42. McGregor I.S., Gurtman C.G., Morley K.C., Kirsten C., Clemens K.J., Blokland A., Li K.M., Cornish J.L., and Hunt G.E. Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology 168 (2003) 465-474
43. Misslin R., and Ropartz P. Effects of methamphetamine on novelty-seeking behaviour by mice. Psychopharmacology 75 (1981) 39-43
44. National Chemicals Inspectorate. Risk Assessment: Piperazine (2004), National Chemicals Inspectorate, Sweden 149 pp.
45. Oberlander C., Euvrard C., Dumont C., and Boissier J.R. Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway. Eur. J. Pharmacol. 60 (1979) 163-170
46. Rawson R.A., Gonzales R., Brethen P., and Paul. Treatment of methamphetamine use disorders: an update. J. Subst. Abuse Treat. 23 (2002) 145-150
47. Rezvani A.H., and Levin E.D. Adolescent and adult rats respond differently to nicotine and alcohol: motor activity and body temperature. Int. J. Dev. Neurosci. 22 (2004) 349-354
48. Simon S.L., Dacey J., Glynn S., Rawson R., and Ling W. The effect of relapse on cognition in abstinent methamphetamine abusers. J. Subst. Abuse Treat. 27 (2004) 59-66
49. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 24 (2000) 417-463
50. Tekes K., László T., Malomvögyi B., Hermán F., and Magyar K. Studies on the biochemical mode of action of EGYT-475, a new antidepressant. Pol. J. Pharmacol. Pharm. 39 (1987) 203-211
51. Vorhees C.V., Reed T.M., Morford L.L., Fukumura M., Wood S.L., Brown C.A., Skelton M.R., McCrea A.E., Rock S.L., and Williams M.T. Periadolescent rats (P41-50) exhibit increased susceptibility to d-methamphetamine-induced long-term spatial and sequential learning deficits compared to juvenile (P21-30 or P31-40) or adult rats (P51-60). Neurotoxicol. Teratol. 27 (2005) 117-134
52. Wegerer V., Moll G.H., Bagli M., Rothenberger A., Ruther E., and Huether G. Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. J. Child Adolesc. Psychopharmacol. 9 (1999) 13-24
53. Wills G.D., Wesley A.L., Moore F.R., and Sisemore D.A. Social interactions among rodent conspecifics: a review of experimental paradigms. Neurosci. Biobehav. Rev. 7 (1983) 315-323